| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |